Medical Tech Merger
SAN DIEGO — Directors are selling Sequenom too cheaply in an unfair process to the Laboratory Corporation of America, for $2.40 per share or $2.5 billion, shareholders claim in Federal Court.
SAN DIEGO — Directors are selling Sequenom too cheaply in an unfair process to the Laboratory Corporation of America, for $2.40 per share or $2.5 billion, shareholders claim in Federal Court.